医学
肾脏疾病
内科学
随机对照试验
临床试验
血压
人口
疾病
梅德林
重症监护医学
政治学
环境卫生
法学
作者
Julia M.T. Colombijn,Demy L. Idema,Sanne van Beem,Anna Marthe Blokland,Kim van der Braak,M. Louis Handoko,Linde F. Huis in ’t Veld,T. K. Kaul,Nurda Kolagasigil-Akdemir,Mike Kusters,Sabine C A Meijvis,Ilse J. Oosting,René Spijker,Michiel L. Bots,Lotty Hooft,Marianne C. Verhaar,Robin W.M. Vernooij
出处
期刊:JAMA network open
[American Medical Association]
日期:2024-03-07
卷期号:7 (3): e240427-e240427
被引量:20
标识
DOI:10.1001/jamanetworkopen.2024.0427
摘要
Patients with chronic kidney disease (CKD) are at high risk for cardiovascular disease, but their systematic underrepresentation in cardiovascular randomized clinical trials (RCTs) limits the generation of appropriate evidence to guide cardiovascular risk management (CVRM).
科研通智能强力驱动
Strongly Powered by AbleSci AI